Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).

P Harter; P Pautier; E Van Nieuwenhuysen; A Reuss; A Redondo; K Lindemann; C Kurzeder; Edgar Petru; F Heitz; J Sehouli; N Degregorio; P Wimberger; A Burges; N Cron; J Ledermann; D Lorusso; X Paoletti; F Marme

doi:10.1136/ijgc-2020-001572

Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).

P Harter
, P Pautier
, E Van Nieuwenhuysen
, A Reuss
, A Redondo
, K Lindemann
, C Kurzeder
, Edgar Petru
, F Heitz
, J Sehouli
, N Degregorio
, P Wimberger
, A Burges
, N Cron
, J Ledermann
, D Lorusso
, X Paoletti
, F Marme

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

8 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	International Journal of Gynecological Cancer
DOIs	https://doi.org/10.1136/ijgc-2020-001572
Publikationsstatus	Veröffentlicht - 2020

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

305 Andere Humanmedizin, Gesundheitswissenschaften
301 Medizinisch-theoretische Wissenschaften, Pharmazie
302 Klinische Medizin

Forschungsfelder

Krebsforschung

Zugriff auf Dokument

10.1136/ijgc-2020-001572

Andere Dateien und Links

Dieses zitieren

Harter, P., Pautier, P., Van Nieuwenhuysen, E., Reuss, A., Redondo, A., Lindemann, K., Kurzeder, C., Petru, E., Heitz, F., Sehouli, J., Degregorio, N., Wimberger, P., Burges, A., Cron, N., Ledermann, J., Lorusso, D., Paoletti, X., & Marme, F. (2020). Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34). International Journal of Gynecological Cancer. https://doi.org/10.1136/ijgc-2020-001572

@article{b6d0c543e780440f9ecb0d11490fa277,

title = "Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).",

author = "P Harter and P Pautier and \{Van Nieuwenhuysen\}, E and A Reuss and A Redondo and K Lindemann and C Kurzeder and Edgar Petru and F Heitz and J Sehouli and N Degregorio and P Wimberger and A Burges and N Cron and J Ledermann and D Lorusso and X Paoletti and F Marme",

year = "2020",

doi = "10.1136/ijgc-2020-001572",

language = "English",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "Elsevier Inc.",

}

Harter, P, Pautier, P, Van Nieuwenhuysen, E, Reuss, A, Redondo, A, Lindemann, K, Kurzeder, C, Petru, E, Heitz, F, Sehouli, J, Degregorio, N, Wimberger, P, Burges, A, Cron, N, Ledermann, J, Lorusso, D, Paoletti, X & Marme, F 2020, 'Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).', International Journal of Gynecological Cancer. https://doi.org/10.1136/ijgc-2020-001572

TY - JOUR

T1 - Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).

AU - Harter, P

AU - Pautier, P

AU - Van Nieuwenhuysen, E

AU - Reuss, A

AU - Redondo, A

AU - Lindemann, K

AU - Kurzeder, C

AU - Petru, Edgar

AU - Heitz, F

AU - Sehouli, J

AU - Degregorio, N

AU - Wimberger, P

AU - Burges, A

AU - Cron, N

AU - Ledermann, J

AU - Lorusso, D

AU - Paoletti, X

AU - Marme, F

PY - 2020

Y1 - 2020

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000607342700021

UR - https://pubmed.ncbi.nlm.nih.gov/32606097

U2 - 10.1136/ijgc-2020-001572

DO - 10.1136/ijgc-2020-001572

M3 - Research article

C2 - 32606097

SN - 1048-891X

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

ER -